PLK1 and cancer: Since amino acid metabolism is linked to the cell cycle, targeting the serine/threonine-protein kinase PLK1 as a cell cycle regulator has been proven a viable therapeutic strategy against cancer chemoresistance (Jain et al., 2012; Shao et al., 2015; Wu et al., 2019).